![Birgit M. Schoeberl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Birgit M. Schoeberl
Eerdere bekende functies van Birgit M. Schoeberl
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2015 | 24-02-2017 |
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - | - |
Opleiding van Birgit M. Schoeberl
University of Karlsruhe | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Duitsland | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Birgit M. Schoeberl
- Ervaring